Joseph G. Pressey

Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study

Mrinal M. Gounder, Patrick Schöffski, Robin L. Jones et al. · The Lancet Oncology · 2020 · 383 citations

Tumor Biology, Medicine, Basket Study +8

Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4

Pilar Ramos, Anthony N. Karnezis, David W. Craig et al. · Nature Genetics · 2014 · 376 citations · Full text

Somatic Variant, Somatic Mutations, Medicine +8

Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors

Mrinal M. Gounder, Ravin Ratan, Thierry Alcindor et al. · New England Journal of Medicine · 2023 · 213 citations · Full text

Severe cytokine release syndrome in a patient receiving PD‐1‐directed therapy

Seth J. Rotz, Daniel Leino, Sara Szabo et al. · Pediatric Blood & Cancer · 2017 · 154 citations

Immunology, Pathology, Immune System +20

Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. A potential mechanism of antigen-specific peripheral lymphocyte deletion

David H. Munn, Joseph G. Pressey, Arthur C. Beall et al. · The Journal of Immunology · 1996 · 105 citations · Full text